Image

Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Patients with Duchenne Muscular Dystrophy.

Recruiting
11 - 30 years of age
Both
Phase N/A

Powered by AI

Overview

  • Objective:

The objective of this observational study is to evaluate and quantify trunk muscle compensatory movement patterns in patients with Duchenne Muscular Dystrophy (DMD) using computer vision technology. Additionally, the study seeks to explore the relationship between these compensatory patterns and scoliosis, upper limb function, pain levels, and quality of life during functional upper limb movements.

  • Key Research Questions:
    1. Can trunk compensatory movement patterns be accurately measured using computer vision analysis? 2) Are these compensatory patterns correlated with scoliosis, upper limb function levels, pain, and quality of life? 3) Do these patterns and their correlations change over time?
  • Methodology:
    1. Participants: Patients diagnosed with Duchenne Muscular Dystrophy will be recruited for this study.
    2. Assessments:
  • Scoliosis Evaluation:
    1. Cobb angle measurement via X-ray imaging.
    2. Upper Limb Function Assessment:
    3. Performance of the Upper Limb Module 2.0 (PUL 2.0).
    4. Brooke Upper Extremity Functional Classification Score.
    5. Korean version of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool (K-DMDSAT).
  • Pain Measurement:
    1. Korean version of the PainDETECT Questionnaire (KPD-Q).
    2. Short Form McGill Pain Questionnaire.
    3. Quality of Life Assessment:
  • Duchenne Muscular Dystrophy Quality of Life Questionnaire (DMD-QoL).
    1. Trunk Compensation Analysis:
  • Surface electromyography (sEMG) to measure muscle activation.
  • Video analysis using computer vision to quantify trunk compensatory movement patterns.
  • The following tasks will be evaluated using the dominant arm for sEMG and video
    analysis
    i. Pouring water into a cup. ii. Lifting a cup to drink water. iii. Grooming the front of the hair. iv. Moving small blocks within one minute (Box and Block Test). v. Reaching toward nearby objects in the front, left, and right directions.
  • Front: Directly in front of the participant's line of sight.
  • Left and right: Approximately 45 degrees to the left and right from the participant's front.
  • Nearby objects: A water bottle or cup weighing approximately 250g, placed at arm's length.

vi. Reaching toward distant objects in the front, left, and right directions.

  • Distant objects: A water bottle or cup weighing approximately 250g, placed at 1.5 times the participant's arm length.
  • The sEMG attachment sites are as follows: i. Muscles for assessing upper limb functional movements:
    1. Deltoid
    2. Pectoralis major
    3. Trapezius
    4. Biceps brachii ii. Muscles for assessing trunk compensatory actions:
    5. Sternocleidomastoid
    6. Longissimus muscle
    7. External oblique abdominal muscle

Eligibility

  1. Inclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group
    • Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy.
    • Aged over 10 years but under 30 years.
    • Brooke Scale score between 2 and 5.
    • Shoulder abductor muscle strength below grade 3 on the Manual Muscle Test (MMT).

      (2) Healthy Control Group

    • Individuals with no history or current diagnosis of musculoskeletal or neuromuscular disorders.
    • Aged over 10 years but under 30 years.
    • Shoulder muscle strength of grade 4+ or higher on the Manual Muscle Test (MMT).
    • Individuals capable of understanding a detailed explanation of the study procedures and voluntarily providing written informed consent. 2. Exclusion Criteria (1) Duchenne Muscular Dystrophy (DMD) Group
    • Individuals unable or unwilling to provide informed consent.
    • Brooke Scale score of 1 or 6.
    • Severe cognitive impairment preventing the performance of simple tasks. (2) Healthy Control Group
    • Individuals unable or unwilling to provide informed consent.
    • Shoulder muscle strength of grade 4 or lower on the Manual Muscle Test (MMT).

Study details

Duchenne Muscular Dystrophy (DMD)

NCT06755138

Seoul National University Hospital

12 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.